A. Rachel Leheny - Jun 24, 2025 Form 4 Insider Report for CalciMedica, Inc. (CALC)

Role: CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
Signature: /s/ John Dunn, Attorney-in-Fact
Stock symbol: CALC
Transactions as of: Jun 24, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/26/2025, 06:26 PM
Previous filing: Apr 25, 2025
Next filing: Jul 15, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Leheny A. Rachel	CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner	C/O CALCIMEDICA, INC., 505 COAST BLVD. S. #307, LA JOLLA	/s/ John Dunn, Attorney-in-Fact	2025-06-26	0001484729

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CALC	Employee Stock Option (Right to Buy)	Award	$0	+77.6K		$0.00	77.6K	Jun 24, 2025	Common Stock	77.6K	$1.53	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025.
F2	Immediately exercisable.